Background-Children with heart disease are frequently exposed to imaging examinations using
Introduction
Children with congenital and acquired heart disease typically undergo imaging procedures that may expose them to large amounts of ionizing radiation. [1] [2] [3] [4] [5] Radiation exposure in childhood is of particular concern because children have immature developing organ and tissue structures. These factors, as well as their potentially longer lifespan, may significantly increase lifetime cancer risk. [6] [7] [8] Previous studies of radiation exposure in children have largely focused on single exposure from various imaging modalities including computed tomography (CT), fluoroscopy, nuclear medicine, and radiographs. [9] [10] [11] [12] [13] [14] [15] Investigators have emphasized that the radiation risk from a single imaging modality can be high. 3, 7, 8, 10, 13, 15 However, children with complex heart diseases are often exposed to repetitive imaging. 16 According to current guidelines from the International Committee on Radiation Protection (ICRP), stochastic exposure risks (i.e. cancer) increase in a linear, dose-response fashion and therefore repetitive exposures are believed to incrementally increase risk. 17 What is currently unknown in young children with heart disease, is the amount of cumulative exposure, the relative contribution of various imaging modalities to cumulative exposure, and the associated lifetime attributable risk (LAR) of cancer.
In a cohort of young children undergoing one of seven operations for congenital and acquired heart disease, we sought to estimate: 1) the cumulative effective dose of radiation exposure across the spectrum of radiation-producing imaging modalities; 2) the relative contribution of various imaging modalities to cumulative effective dose; and 3) the estimated LAR of cancer from cumulative radiation exposure.
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Methods

Study Population
Children were eligible for inclusion if they were 6 years of age and had previously undergone one of seven different primary surgical procedures for heart disease, including isolated atrial septal defect closure, isolated ventricular septal defect (VSD) closure, atrioventricular canal defect (AVCD) repair (including complete, transitional, and partial AVCD), tetralogy of Fallot repair (excluding patients with tetralogy/AVCD, pulmonary atresia or tetralogy with absent pulmonary valve), isolated arterial switch operation (excluding arterial switch ± VSD and / or coarctation repair), cardiac transplant, and Norwood operation, at a single institution between July 1, 2005, and December 31, 2010. Surgical procedures used for study entry were chosen to represent more commonly performed surgical procedures and also a spectrum of surgical complexity. Patients were grouped according to their initial surgical procedure unless their course ended in a cardiac transplantation, in which case they were analyzed in the transplant group. This study was approved by the Duke University Medical Center institutional review board with waiver of informed consent.
Data Collection
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demonstrated <5% missing data.
Effective Dose Calculation
Cardiac catheterization
Organ-specific radiation doses were measured using 2 ATOM family (CIRS, Norfolk, VA)
anthropomorphic phantoms (representing 1 and 5 years of age). The phantoms include sectional slabs, each with a thickness of 25 mm, and are manufactured using tissue/organ-equivalent epoxy resins (including bone density formulated to represent a 1-and 5-year-old skeleton de dev ve velo lo lop p p a a pr pr pro op opri riet eta ar ary y y ra radi di d at a i ion on o d d dos os ose e e ca ca alc c cul ul ula at ator or r w wh hi hic ch c w was as as t t the he en n n u u used ed ed t to o o d de dete term rm rmin in i e e to to ot tal l l catheterizatio on n n ef ef e fe fe fect ct c iv iv ve e e do o ose se se by y y e e ent nt ter e e in in ing g g fl fl fluo uo uoro ro osc sc s op op opy y y an an and d d ci ci cine ne ean an angi gi iog og ogra ra raph ph phy y y ti time me mes s s an an and d d camera performed on a Philips Integris Allura 9 (Philips Healthcare, Netherlands) fluoroscopy system.
Other imaging modalities
Age-specific effective dose estimates for all other radiographic examinations were derived from a combination of previously published institutional data estimated using phantoms (upper gastrointestinal series with small bowel follow through, chest CT, cardiac gated CT angiography, abdomen/pelvis multi-detector array CT, chest CT) and data from the peer-reviewed radiology literature (Supplemental Table 1 ). A central tendency value was used to define the effective dose of an examination in cases of several source estimates.
Cumulative effective dose estimates were calculated by summing effective doses over each patient's imaging history. The average annual effective dose was defined as the average effective dose per year from birth to the time of last data collection. The post-operative effective dose was defined as the effective dose within the first 3 months after the initial surgical procedure.
LAR Cancer Estimation
Radiation dose was estimated by organ system and summed to estimate effective dose.
Cumulative risk of cancer and age-and sex-specific LAR of cancer above baseline was estimated based on the effective dose using the approach of the National Academy of Sciences Committee on Biological Effects of Ionizing Radiation (BEIR) VII. 18 The lower and upper limit cancer risk estimations were calculated using the BEIR VII 5% and 95% risk estimates for exposure. These limits were calculated individually for each examination in each patient. The BEIR VII models assume a normal life expectancy, take into account the age at exposure and the sex of the population, and assume that cancer risk is proportional to the radiation dose with no threshold.
Therefore, every ionizing radiation-producing procedure performed on an individual produces a each patient's imaging history. The average annual effective dose was defined as as s the he h a a ave ve vera ra rage ge ge effective dose per year from birth to the time of last data collection. The post-operative effective do ose se se w w was as d d def ef efi i ined ed d a a as s the effective dose within th he e e fi fir rst 3 months a aft ft f er t the he he i initial surgical proc c ced e ure.
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corresponding increase in cancer risk. To calculate cancer risk in our high risk population with anticipated shorter life expectancy, excess relative cancer risk was calculated at 0.035 / 1 mSv exposure at mean follow-up of 10 years based on previous epidemiologic data. 19 For calculations, exposure was assumed to have occurred at age 5 years. Background cancer rates were based on reported U.S. 5-year cancer incidence for adolescents (ages 15-19 years).
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Statistical Analysis
The unit of observation for this analysis was a subject enrolled in the study. Summary statistics were used to describe the study variables, including means and standard deviations and frequency counts and percentages. Distribution of effective dose and LAR across procedure types were compared using a non-parametric Kruskal Wallis test. All analyses were conducted using Stata 12.0 (College Station, TX), and a 2-tailed p-value<0.05 was considered statistically significant.
Results
Clinical characteristics are presented by surgical subgroup in Table 1 . The study cohort consisted of 337 children undergoing one of seven surgical procedures of interest. For the overall cohort, median age at surgery was 88 days (5 th -95 th percentile 3-819), and median duration of follow-up from birth was 23.9 months (5 th -95 th percentile 1.6-60.9).
The numbers of radiation-producing examinations, average annual, and cumulative effective dose per operative group are listed in 
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Clinical chara ra act ct cter er ris is isti ti t cs cs s a a are e e p p pr r res esen en ente ted d d by by y s s sur ur urgi gi gica ca cal l su su subg bg bgro o oup up up i in n n Ta Ta Tabl ble e e 1 1 1. . Th Th The e e st stud ud udy y y co co coho ho h rt transplant and Norwood cohorts) received substantially greater cumulative exposure. In terms of timing of examinations, the majority were performed in the first 3 months after the entry surgical procedure (6,992/13,932, 50%) , but these immediate post-operative examinations accounted for only 26% of cumulative exposure (range 23-36% for the 7 surgical sub-groups). The transplant patients represent a unique cohort in that they frequently have complex pre-transplant medical needs, particularly in those with a prior history of congenital heart disease (70% of our cohort).
In these patients, post-transplant radiation accounted for the majority of exposure (72%) with a median post-transplant cumulative effective dose of 45.8 mSv (5 th -95 th percentile 7.4-154.2). Table 3 shows the relative contribution of radiation-producing examinations to the total cumulative effective dose. Conventional radiographic examinations represented 92% of total examinations but accounted for only 8% of the cumulative effective dose. Conversely, cardiac catheterization procedures represented 1.5% (n=303/13,932) of all examinations but contributed 60% of total radiation exposure (Figure 1) . CT angiography of the chest, followed by interventional catheterization examinations, accounted for the highest effective dose per study ( Table 3 ).
The estimated LAR of cancer above baseline per operative group and examination modality is listed in Table 4 . Median LAR across surgical cohorts was 65 cases/100,000 children exposed. Lower (43 cases per 100,000 exposed) and upper limits (112 cases / 100,000 exposed) of LAR represent the median cohort 5% and 95% LAR respectively based on the BEIR VII confidence intervals. LAR of cancer per unit exposure was substantially greater in females (41/100,000 versus 22/100,000 per 1 mSv effective dose for females versus males respectively, p<0.001), primarily reflecting increased breast and thyroid cancer risk. The LAR per individual radiation-producing examination varied widely depending on examination, exceeding 350 cumulative effective dose. Conventional radiographic examinations represented d 9 92 92% % % of of of t t tot ot otal al al a examinations but accounted for only 8% of the cumulative effective dose. Conversely, cardiac ca ath th het et ete er eriz iz izat at atio io ion pr pr ro oc ocedures represented 1.5% (n= = =3 3 303 3/13,932) of a all ll l ex xam am min inations but contributed 6 60 0% % % of total r rad ad dia i i t t tion on exp xp xpo os osur ur ure e ( (F Fi Fig gu gure re 1) . C CT T an n ng g giog g gra ra aph ph hy y of of t t the he e c che he hest t, , fo fo oll ll llow owed ed ed b b by y n nte te terv rv ven en e ti tion on onal a al c ca at ath he hete ter r riz za zati tion n n ex x xam am ami in inat at tio o ons ns ns, , , ac c cco co c un un unte t d d d fo fo for r r t th the e e hi hi igh gh ghes es est t ef ef effe fe f ct ct tiv iv ive e e do do ose se se p p pe er er s stu tudy dy dy Table 3 ).
by guest on April 19, 2017 http://circ.ahajournals.org/ Downloaded from cases/100,000 children exposed to a CT angiography of the chest and interventional catheterization but only 0.2 cases/100,000 children exposed to a portable chest x-ray (Figure 2) .
As the cardiac transplant and Norwood cohorts may not have a normal anticipated life expectancy, we also estimated relative cancer risk in the short term for these two cohorts. Based on cumulative exposure, the median 10-year sex-averaged relative risk of any cancer compared to an unexposed population was 3.2 (5%, 95%: 1.4-7.7) for the transplant cohort and 2.0 (5%, 
Discussion
This is the largest study evaluating cumulative radiation exposure across the spectrum of imaging modalities to estimate the associated LAR of cancer in children with heart disease.
While commonly performed, radiographs contribute a relatively small proportion to total radiation exposure. Conversely, less commonly performed but higher exposure imaging modalities such as catheterization and chest CT are the most important contributors to cumulative radiation exposure and, therefore, lifetime cancer risk.
In the United States and internationally, use of radiation-producing imaging examinations in children continues to rise. 7 Although children benefit from advanced imaging procedures for more accurate diagnosis and less-invasive treatment, radiation has potential health risks. Several studies have shown that for a given dose of radiation, children are 3-4 times more likely than adults to develop malignancies. 2, 6, 18 Risk associated with radiation exposure is particularly relevant for children with more
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Even in the limited time frame studied, the estimated LAR of cancer above baseline was as high as 6.5%. Shortened anticipated lifespan in these high risk cohorts does not mitigate cancer mortality and morbidity risks as they have a significantly increased relative risk of cancer even within the first 10 years following exposure. These data are consistent with epidemiologic data demonstrating that relative risk of cancer is highest in the early years after exposure. 18 Conversely, for children with lower complexity heart disease, and a presumably less complicated course, exposure was reassuringly low. For five of the seven procedure cohorts, the median annual ED (0.09 -0.29 mSv) from imaging procedures was substantially below the annual background exposure within the United States (3.0-3.5 mSv). 21 Nonetheless, LAR of cancer exceeded 0.5% at the upper limits of exposure for 6/7 cohorts with the notable exception of children following arterial switch operation.
These data provide actionable information that could be employed to reduce exposure and suggest that the greatest risk reduction can be achieved with a targeted approach focused on minimizing radiation use during high-exposure examinations such as catheterization and CT.
Although less frequently performed, these modalities are the main contributors to cumulative effective dose and can contribute up to 1,800 times as much effective dose per examination as a standard radiograph. In our cohort, higher-risk patients were frequently exposed to these highexposure imaging modalities repeatedly beyond the immediate post-operative period and consequently had much higher average annual effective dose. Conversely, conventional radiographic examinations were primarily performed during the immediate post-operative period and, although high in volume, contributed a relatively small amount of cumulative effective dose. This finding is consistent with prior publications. 16 It is also important to recognize that background exposure within the United States (3.0-3.5 mSv). 21 Nonetheless, LAR AR AR o o of f f ca c canc nc ncer er er exceeded 0.5% at the upper limits of exposure for 6/7 cohorts with the notable exception of ch hil il ldr dr dren en en f f fol ol ollo lo lowi ing ng ng a arterial switch operation.
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risk of cancer was substantially higher in the female population due to the increased risk of breast and thyroid cancer. 18 Strengths of this current analysis include the large sample size, and our comprehensive approach to estimating effective dose. Our effective dose data are particularly robust as many of the effective dose calculations (including the highest exposure modalities-chest CT and catheterization) were obtained using data from dosimeters placed over vital tissue structures in anthropomorphic phantoms. 15 In the case of the catheterization procedures, these data were then combined with actual patient data on fluoroscopic and cineangiographic times and camera
angles. This allowed us to directly measure organ-specific exposures. The median effective dose from therapeutic and diagnostic cardiac catheterization procedures (13.77 mSv and 9.10 mSv) was higher than in previous publications. 2-4 However, these previous publications all used simulation models to calculate an effective dose in mSv from the reported skin exposure represented in milligray. [2] [3] [4] Estimates of skin exposure calculated by the equipment from technical parameters may introduce error depending on the equipment. External exposure data also fails to account for beam attenuation and other factors that alter absorbed radiation dose.
Therefore these data are generally less accurate. Although phantom data are more robust, there are also limits as phantoms do not perfectly approximate the clinical setting where factors including body habitus, ergonomics, anatomy and variation in imaging parameters all uniquely affect exposure.
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varied for the specific cohorts, and a meaningful number of patients died during follow up. These factors lead unavoidably to an approximation that likely underestimates the total radiation exposure and may bias relative estimates in select cohorts. Second there is variability in the dose of each radiation examination and while phantom data provide the most accurate estimate of our institutional exposure, they may not be directly generalizable to institutions using different imaging protocols or equipment. 15, 22 A third limitation is that cancer estimates using BEIR VII tables are subject to sources of uncertainty due to inherent limitations in epidemiological data and in the general understanding of how radiation exposure increases the risk of cancer.
Moreover, we used effective dose to calculate LAR, whereas the BEIR VII data use summed cancer risks for individual organs following a total-body exposure. Although the use of effective dose in this context is not strictly correct, it has been shown that the 2 approaches yield similar values of LAR.
23-26
Conclusions
The effective dose from radiation-producing imaging examinations varies greatly across the spectrum of imaging modalities. Overall, for our patient cohort, cumulative effective dose was relatively low, less than the annual background exposure in the U.S. However select children with complex heart disease can be exposed to large cumulative doses that increase the estimated LAR of cancer to up to 6.5% above baseline, even in the limited time frame studied. Highexposure imaging modalities such as catheterization and CT are the most important contributors to the cumulative effective dose. To reduce long term cancer risk, providers should target reducing radiation exposure in the highest risk cohorts including those children that will require repetitive high-exposure imaging and females because of their increased cancer risk. Providers cancer risks for individual organs following a total-body exposure. Although the e u use se e o o of f f ef ef effe fe fect ct c i ive dose in this context is not strictly correct, it has been shown that the 2 approaches yield similar va alu lu ues es s o of f f LA LA LAR R R. 23 23-3-26 6 2 Co Co onc nc nclu lu lusi sion on ons s s
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